Skip to main content

Metastatic Cutaneous Squamous Cell Carcinoma of the Head and Neck

  • Chapter
  • 811 Accesses

Part of the book series: Head and Neck Cancer Clinics ((HNCC))

Abstract

Non-melanoma skin cancer (NMSC), comprising basal cell carcinoma (BCC) and cutaneous squamous cell carcinoma (cSCC), is the most common malignancy worldwide. The incidence of NMSC is increasing with 2–3 million new diagnoses per year globally. Australia, with chronic high ultraviolet (UV) exposure, has the highest incidence of NMSC in the world, with the majority of cSCCs (70–90 %) arising on the sun-exposed skin of the head and neck (HN) in older Caucasian males [1–4].

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. de Vries E, van de Poll-Franse LV, Louwman WJ, et al. Predictions of skin cancer incidence in the Netherlands up to 2015. Br J Dermatol. 2005;152:481–8.

    Article  PubMed  Google Scholar 

  2. Locke J, Karimpour S, Young G, et al. Radiotherapy for epithelial skin cancers. Int J Radiat Oncol Biol Phys. 2001;51:748–55.

    Article  CAS  PubMed  Google Scholar 

  3. Veness MJ, Porceddu S, Palme CE, et al. Cutaneous head and neck squamous cell carcinoma metastatic to parotid and cervical lymph nodes. Head Neck. 2007;29:621–31.

    Article  PubMed  Google Scholar 

  4. Ebrahimi A, Moncrieff MD, Clark JR, et al. Predicting the pattern of regional metastases from cutaneous squamous cell carcinoma of the head and neck based on location of the primary. Head Neck. 2010;32:1288–94.

    Article  PubMed  Google Scholar 

  5. Rodgers HW, Weinstock MA, Harris AR, et al. Incidence estimate of nonmelanoma skin cancer in the United States, 2006. Arch Dermatol. 2010;146:283–7.

    Google Scholar 

  6. Buettner PG, Raasch BA. Incidence rates of skin cancer in Townsville, Australia. Int J Cancer. 1998;78:587–93.

    Article  CAS  PubMed  Google Scholar 

  7. Staples M, Marks R, Giles G. Trends in the incidence of non-melanocytic skin cancer (NMSC) treated in Australia 1985–1995: are primary prevention programs starting to have an effect? Int J Cancer. 1998;78:144–8.

    Article  CAS  PubMed  Google Scholar 

  8. Brantsch KD, Meisner C, Schönfisch B, et al. Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study. Lancet Oncol. 2008;9:713–20.

    Article  PubMed  Google Scholar 

  9. Katz MH. Nonmelanoma skin cancer. Md Med J. 1997;46:239–42.

    CAS  PubMed  Google Scholar 

  10. Marcil I, Stern RS. Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer: a critical review of the literature and meta-analysis. Arch Dermatol. 2000;136:1524–30.

    Article  CAS  PubMed  Google Scholar 

  11. Schmults CD, Karia PS, Carter JB, et al. Factors predictive of recurrence and death from cutaneous squamous cell carcinoma: a 10-year, single-institution cohort study. JAMA Dermatol. 2013;149:541–7.

    Article  PubMed  Google Scholar 

  12. Motley RJ, Kersey P, Lawrence CM. Multi-professional guidelines for the management of the patient with primary cutaneous squamous cell carcinoma. Br J Dermatol. 2003;56:85–91.

    CAS  Google Scholar 

  13. Czarnecki D, Staples M, Mar A, et al. Metastases from squamous cell carcinoma of the skin in southern Australia. Dermatology. 1994;189:52–4.

    Article  CAS  PubMed  Google Scholar 

  14. Wang JT, Palme CE, Morgan GJ, et al. Predictors of outcome in patients with metastatic cutaneous head and neck squamous cell carcinoma involving cervical lymph nodes: improved survival with the addition of adjuvant radiotherapy. Head Neck. 2011;34:1524–8.

    Article  PubMed  Google Scholar 

  15. Peat B, Insull P, Ayers R. Risk stratification for metastasis from cutaneous squamous cell carcinoma of the head and neck. ANZ J Surg. 2012;82:230–3.

    Article  PubMed  Google Scholar 

  16. Oddone N, Morgan GJ, Palme CE, et al. Metastatic cutaneous squamous cell carcinoma of the head and neck: the Immunosuppression, Treatment, Extranodal spread and Margin status (ITEM) prognostic score to predict outcome and the need to improve survival. Cancer. 2009;115:1883–91.

    Article  PubMed  Google Scholar 

  17. Givi B, Andersen PE, Diggs BS, et al. Outcome of patients treated surgically for lymph node metastases from cutaneous squamous cell carcinoma of the head and neck. Head Neck. 2011;33:999–1004.

    Article  PubMed  Google Scholar 

  18. Nolan RC, Chan MT, Heenan PJ. A clinicopathologic review of lethal nonmelanoma skin cancers in Western Australia. J Am Acad Dermatol. 2005;52:101–8.

    Article  PubMed  Google Scholar 

  19. Veness MJ, Morgan GJ, Palme CE, et al. Surgery and adjuvant radiotherapy in patients with cutaneous head and neck squamous cell carcinoma metastatic to lymph nodes: combined treatment should be considered best practice. Laryngoscope. 2005;115:870–5.

    Article  PubMed  Google Scholar 

  20. Motley RJ, Preston PW, Lawrence CM. Multi-professional guidelines for the management of the patient with primary cutaneous squamous cell carcinoma. London: British Association of Dermatology (BAD); 2009. p. 34. http://www.guideline.gov/content.aspx?id=15882.

  21. National Comprehensive Cancer Network (NCCN). Practice guidelines in oncology: basal cell and squamous cell skin cancers. Available at www.nccn.org/professionals/5hysician_gls/PDF/nmsc.pdf. Accessed on 24 Sept 2013.

  22. Vauterin TJ, Veness MJ, Morgan GJ, et al. Patterns of lymph node spread of cutaneous squamous cell carcinoma of the head and neck. Head Neck. 2006;28:785–91.

    Article  PubMed  Google Scholar 

  23. Hinerman RW, Indelicato DJ, Amdur RJ, et al. Cutaneous squamous cell carcinoma metastatic to parotid-area lymph nodes. Laryngoscope. 2008;118:1989–96.

    Article  PubMed  Google Scholar 

  24. Rowe DE, Carroll RJ, Day Jr CL. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear and lip. J Am Acad Dermatol. 1992;26:976–90.

    Article  CAS  PubMed  Google Scholar 

  25. Dinehart SM, Pollack SV. Metastases from squamous cell carcinoma of the skin and lip. J Am Acad Dermatol. 1989;21:241–8.

    Article  CAS  PubMed  Google Scholar 

  26. Stein AL, Tahan SR. Histologic correlates of metastasis in primary invasive squamous cell carcinoma of the lip. J Cutan Pathol. 1994;21:16–21.

    Article  CAS  PubMed  Google Scholar 

  27. Kraus DH, Carew JF, Harrison LB. Regional lymph node metastasis from cutaneous squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 1998;124:582–7.

    Article  CAS  PubMed  Google Scholar 

  28. Rodolico V, Barresi E, Di Lorenzo R, et al. Lymph node metastasis in lower lip squamous cell carcinoma in relation to tumour size, histologic variables and p27kip1 protein expression. Oral Oncol. 2004;40:92–8.

    Article  CAS  PubMed  Google Scholar 

  29. Breuninger H, Black B, Rassner G. Microstaging of squamous cell carcinomas. Am J Clin Pathol. 1990;94:624–7.

    CAS  PubMed  Google Scholar 

  30. Cassarino DS, Derienzo DP, Barr RJ. Cutaneous squamous cell carcinoma: a comprehensive clinicopathologic classification—part two. J Cutan Pathol. 2006;33:261–79.

    Article  PubMed  Google Scholar 

  31. Breuninger H, Schaumburg-Lever G, Holzschuh J, et al. Desmoplastic squamous cell carcinoma of the skin and vermilion surface: a highly malignant subtype of skin cancer. Cancer. 1997;79:915–9.

    Article  CAS  PubMed  Google Scholar 

  32. Ballantyne AJ. Perineural invasion by squamous cell carcinoma. J Dermatol Surg Oncol. 1984;10:502–4.

    Article  CAS  PubMed  Google Scholar 

  33. Leibovitch I, Huilgol SC, Selva D, et al. Cutaneous squamous cell carcinoma treated with Moh’s micrographic surgery in Australia II. Perineural invasion. J Am Acad Dermatol. 2005;53:261–6.

    Article  PubMed  Google Scholar 

  34. Ross AS, Whalen FM, Elenitsas R, et al. Diameter of involved nerves predicts outcome in cutaneous squamous cell carcinoma with perineural invasion: an investigator blinded retrospective cohort study. Dermatol Surg. 2009;35:1859–66.

    Article  CAS  PubMed  Google Scholar 

  35. https://intranet.som.uq.edu.au/PNIRegistry.

  36. Brougham ND, Dennett ER, Cameron R, et al. The incidence of metastasis from cutaneous squamous cell carcinoma and the impact of its risk factors. J Surg Oncol. 2012;106:811–5.

    Article  PubMed  Google Scholar 

  37. Huang CC, Boyce SM. Surgical margins of excision for basal cell carcinoma and squamous cell carcinoma. Semin Cutan Med Surg. 2004;23:163–73.

    Article  Google Scholar 

  38. Brodland DG, Zitelli JA. Surgical margins for excision of primary cutaneous squamous cell carcinoma. J Am Acad Dermatol. 1992;27:241–8.

    Article  CAS  PubMed  Google Scholar 

  39. Thomas DJ, King AR, Peat BG. Excision margins for nonmelanotic skin cancer. Plast Reconstr Surg. 2003;112:57–63.

    Article  PubMed  Google Scholar 

  40. Leibovitch I, Huilgol SC, Selva D, et al. Cutaneous squamous cell carcinoma treated with Moh’s micrographic surgery in Australia I. Experience over 10 years. J Am Acad Dermatol. 2005;53:253–60.

    Article  PubMed  Google Scholar 

  41. Duvvuri U, Simental Jr AA, D’Angelo G, et al. Elective neck dissection and survival in patients with squamous cell carcinoma of the oral cavity and oropharynx. Laryngoscope. 2004;114:2228–34.

    Article  PubMed  Google Scholar 

  42. Morton DL, Cochran AJ, Thompson JF, et al. Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-1, an international multicenter trial. Ann Surg. 2005;242:302–11; discussion 311–13.

    PubMed Central  PubMed  Google Scholar 

  43. Fields RC, Busam KJ, Chou JF, et al. Recurrence and survival in patients undergoing sentinel lymph node biopsy for merkel cell carcinoma: analysis of 153 patients from a single institution. Ann Surg Oncol. 2011;18:2529–37.

    Article  PubMed Central  PubMed  Google Scholar 

  44. Howle J, Veness M. Sentinel lymph node biopsy in patients with Merkel cell carcinoma: an emerging role and the Westmead Hospital experience. Australas J Dermatol. 2012;53:26–31.

    Article  PubMed  Google Scholar 

  45. Morton DL. Overview and update of the phase III MSLT-I and MSLT-II in melanoma. Clin Exp Metastasis. 2012;29:699–706.

    Article  PubMed Central  PubMed  Google Scholar 

  46. Vermeeren L, Valdés Olmos RA, Klop WM, et al. SPECT/CT for sentinel lymph node mapping in head and neck melanoma. Head Neck. 2011;33:1–6.

    Article  PubMed  Google Scholar 

  47. Civantos FJ, Moffat FL, Goodwin WJ. Lymphatic mapping and sentinel lymphadenectomy for 106 head and neck lesions: contrasts between oral cavity and cutaneous malignancy. Laryngoscope. 2006;112 Suppl 109:1–15.

    Article  PubMed  Google Scholar 

  48. Altinyollar H, Berberoglu U, Çelen O, et al. Lymphatic mapping and sentinel lymph node biopsy in squamous cell carcinoma of the lower lip. Eur J Surg Oncol. 2002;28:72–4.

    Article  CAS  PubMed  Google Scholar 

  49. Kwon S, Dong ZM, Wu PC. Sentinel lymph node biopsy for high-risk cutaneous squamous cell carcinoma: clinical experience and review of literature. World J Surg Oncol. 2011;9:80.

    Article  PubMed Central  PubMed  Google Scholar 

  50. http://www.shnci.org/snic-trial.html.

  51. Wong G, Chapman JR. Cancers after renal transplantation. Transplant Rev. 2008;22:141–9.

    Article  Google Scholar 

  52. Hartevelt MM, Bavinck JN, Kootte AM, et al. Incidence of skin cancer after renal transplantation in The Netherlands. Transplantation. 1990;49:506–9.

    Article  CAS  PubMed  Google Scholar 

  53. Jensen P, Hansen S, Møller B, et al. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol. 1999;40:177–86.

    Article  CAS  PubMed  Google Scholar 

  54. Lindelöf B, Sigurgeirsson B, Gäbel H, et al. Incidence of skin cancer in 5356 patients following organ transplantation. Br J Dermatol. 2000;143:513–9.

    PubMed  Google Scholar 

  55. Cooper JZ, Brown MD. Special concern about squamous cell carcinoma of the scalp in organ transplant recipients. Arch Dermatol. 2006;142:755–8.

    PubMed  Google Scholar 

  56. Deeb R, Sharma S, Mahan M, et al. Head and neck cancer in transplant recipients. Laryngoscope. 2012;122:1566–9.

    Article  PubMed  Google Scholar 

  57. Bouwes Bavinck JN, Hardie DR, Green A, et al. The risk of skin cancer in renal transplant recipients in Queensland, Australia. A follow-up study. Transplantation. 1996;61:715–21.

    Article  CAS  PubMed  Google Scholar 

  58. Webb MC, Compton F, Andrews PA, et al. Skin tumours post-transplantation: a retrospective analysis of 28 years’ experience at a single centre. Transplant Proc. 1997;29:828–30.

    Article  CAS  PubMed  Google Scholar 

  59. Veness MJ. The important role of radiotherapy in patients with NMSC and other cutaneous entities. J Med Imaging Radiat Oncol. 2008;52:278–86.

    Article  CAS  PubMed  Google Scholar 

  60. Jambusaria-Pahlajani A, Miller CJ, Quon H, et al. Surgical monotherapy versus surgery plus adjuvant radiotherapy in high-risk cutaneous squamous cell carcinoma: a systematic review of outcomes. Dermatol Surg. 2009;35:574–85.

    Article  CAS  PubMed  Google Scholar 

  61. Han A, Ratner D. What is the role of adjuvant radiotherapy in the treatment of cutaneous squamous cell carcinoma with perineural invasion? Cancer. 2007;109:1053–9.

    Article  PubMed  Google Scholar 

  62. Mendenhall WM, Ferlito A, Takes RP, et al. Cutaneous head and neck basal and squamous cell carcinomas with perineural invasion. Oral Oncol. 2012;48:918–22.

    Article  PubMed  Google Scholar 

  63. Jambusaria-Pahlajani A, Hess SD, Katz KA, et al. Uncertainty in the perioperative management of high-risk cutaneous squamous cell carcinoma among Mohs surgeons. Arch Dermatol. 2010;146:1225–31.

    Article  PubMed  Google Scholar 

  64. Panizza B, Solares CA, Redmond M, et al. Surgical resection for clinical perineural invasion from cutaneous squamous cell carcinoma of the head and neck. Head Neck. 2012;34:1622–7.

    Article  PubMed  Google Scholar 

  65. Hwang H, Perez D, Orloff L. Comparison of positron emission tomography/computed tomography imaging and ultrasound in staging and surveillance of head and neck and thyroid cancer. Laryngoscope. 2009;119:1958–65.

    Article  PubMed  Google Scholar 

  66. Bron LP, Traynor SJ, McNeil EB, et al. Primary and metastatic cancer of the parotid: comparison of clinical behavior in 232 cases. Laryngoscope. 2003;113:1070–5.

    Article  PubMed  Google Scholar 

  67. Uren RF. Lymphatic drainage of skin. Ann Surg Oncol. 2004;11(3 Suppl):179S–85.

    Article  PubMed  Google Scholar 

  68. Forest VI, Clark JJ, Veness MJ, et al. N1S3: a revised staging system for head and neck cutaneous squamous cell carcinoma with lymph node metastases: results of 2 Australian Cancer Centers. Cancer. 2010;116:1298–304.

    Article  PubMed  Google Scholar 

  69. Kelder W, Ebrahimi A, Forest V, et al. Cutaneous head and neck squamous cell carcinoma with regional metastases: the prognostic importance of soft tissue metastases and extranodal spread. Ann Surg Oncol. 2012;19:274–9.

    Article  PubMed Central  PubMed  Google Scholar 

  70. O’Brien CJ, McNeil EB, McMahon JD, et al. Significance of clinical stages, extent of surgery and pathologic findings in metastatic cutaneous squamous cell carcinoma of the parotid gland. Head Neck. 2002;24:417–22.

    Article  PubMed  Google Scholar 

  71. Andruchow JL, Veness MJ, Morgan GJ, et al. Implications for clinical staging of metastatic cutaneous squamous carcinoma of the head and neck based on a mulitcenter study of treatment outcomes. Cancer. 2006;106:1078–83.

    Article  PubMed  Google Scholar 

  72. American Joint Committee on Cancer. AJCC cancer staging handbook. Cutaneous squamous cell carcinoma and other cutaneous carcinomas. In: Edge SB, Byrd DR, Compton CC, et al., editors. AJCC cancer staging manual. 7th ed. New York: Springer; 2010. p. 301–14.

    Chapter  Google Scholar 

  73. Brunner M, Veness MJ, Ch’ng S, et al. Distant metastases from cutaneous squamous cell carcinoma—analysis of AJCC stage IV. Head Neck. 2013;35:72–5.

    Article  PubMed  Google Scholar 

  74. O’Hara J, Ferlito A, Takes RP, et al. Cutaneous squamous cell carcinoma of the head and neck metastasizing to the parotid gland—a review of current recommendations. Head Neck. 2011;33:1789–95.

    Article  PubMed  Google Scholar 

  75. Ambrosch P, Kron M, Pradier O, et al. Efficacy of selective neck dissection: a review of 503 cases of elective and therapeutic treatment of the neck in squamous cell carcinoma of the upper aerodigestive tract. Otolaryngol Head Neck Surg. 2001;124:180–7.

    Article  CAS  PubMed  Google Scholar 

  76. Chepeha DB, Hoff PT, Taylor RJ, et al. Selective neck dissection for the treatment of neck metastasis from squamous cell carcinoma of the head and neck. Laryngoscope. 2002;112:434–8.

    Article  PubMed  Google Scholar 

  77. Patel RS, Clark JR, Gao K, et al. Effectiveness of selective neck dissection in the treatment of the clinically positive neck. Head Neck. 2008;30:1231–6.

    Article  PubMed  Google Scholar 

  78. Shepard PM, Olsen J, Harari PM, et al. Therapeutic selective neck dissection outcomes. Otolaryngol Head Neck Surg. 2010;142:741–6.

    Article  PubMed  Google Scholar 

  79. Robbins KT, Ferlito A, Shah JP, et al. The evolving role of selective neck dissection for head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol. 2013;270:1195–202.

    Article  PubMed  Google Scholar 

  80. Wang JT, Palme CE, Wang AY, et al. In patients with metastatic cutaneous head and neck squamous cell carcinoma to cervical lymph nodes, the extent of neck dissection does not influence outcome. J Laryngol Otol. 2013;127 Suppl 1:S2–7.

    Article  PubMed  Google Scholar 

  81. D’Souza J, Clark J. Management of the neck in metastatic cutaneous squamous cell carcinoma of the head and neck. Curr Opin Otolaryngol Head Neck. 2011;19:99–105.

    Article  Google Scholar 

  82. Iyer NG, Clark JR, Murali R, et al. Outcomes following parotidectomy for metastatic squamous cell carcinoma with microscopic residual disease: implications for facial nerve preservation. Head Neck. 2009;31:21–7.

    Article  PubMed  Google Scholar 

  83. Cappiello J, Piazza C, Giudice M, et al. Shoulder disability after different selective neck dissections (levels II–IV versus levels II–V): a comparative study. Laryngoscope. 2005;115:259–63.

    Article  PubMed  Google Scholar 

  84. Stuiver MM, van Wilgen CP, de Boer EM, et al. Impact of shoulder complaints after neck dissection on shoulder disability and quality of life. Otolaryngol Head Neck Surg. 2008;139:32–9.

    Article  PubMed  Google Scholar 

  85. Veness MJ, Palme CE, Smith M, et al. Cutaneous head and neck squamous cell carcioma metastatic to cervical lymph nodes (non-parotid): a better outcome with surgery and adjuvant radiotherapy. Laryngoscope. 2003;113:1827–33.

    Article  PubMed  Google Scholar 

  86. Mendenhall WM, Amdur RJ, Hinerman RW, et al. Radiotherapy for cutaneous squamous and basal cell carcinomas of the head and neck. Laryngoscope. 2009;119:1994–9.

    Article  PubMed  Google Scholar 

  87. Ebrahimi A, Clark J, Lorincz BB, et al. Metastatic head and neck cutaneous squamous cell carcinoma: defining a low-risk patient. Head Neck. 2012;34:365–70.

    Article  PubMed  Google Scholar 

  88. Euvrard S, Morelon E, Rostaing L, TUMORAPA Study Group, et al. Sirolimus and secondary skin-cancer prevention in kidney transplantation. N Engl J Med. 2012;367:329–39.

    Article  CAS  PubMed  Google Scholar 

  89. Pramana A, Browne L, Graham PH. Metastatic cutaneous squamous cell carcinoma to parotid nodes: the role of bolus with adjuvant radiotherapy. J Med Imaging Radiat Oncol. 2012;56:100–8.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Carolyn Jameson FRACS, PhD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Faruque Riffat, Carsten E. Palme, Michael Veness, Rehan Kazi, Raghav C. Dwivedi

About this chapter

Cite this chapter

Jameson, C., Morgan, G., Palme, C.E., Veness, M. (2015). Metastatic Cutaneous Squamous Cell Carcinoma of the Head and Neck. In: Riffat, F., Palme, C., Veness, M. (eds) Non-melanoma Skin Cancer of the Head and Neck. Head and Neck Cancer Clinics. Springer, New Delhi. https://doi.org/10.1007/978-81-322-2497-6_8

Download citation

  • DOI: https://doi.org/10.1007/978-81-322-2497-6_8

  • Publisher Name: Springer, New Delhi

  • Print ISBN: 978-81-322-2496-9

  • Online ISBN: 978-81-322-2497-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics